All patients (N = 154) | Survivors (N = 54) | Nonsurvivors (N = 100) | p value | |
---|---|---|---|---|
Age (yr) | 51.7 (38.0–69.0) | 43.1 (28.0–62.0) | 56.4 (42.5–70.0) | <0.001 |
Male (n, %) | 111 (72.1) | 35 (64.8) | 76 (76) | 0.103 |
Charlson score | 0.8 (0–1.0) | 0.6 (0–1.0) | 1.0 (0–1.0) | 0.18 |
Body mass index >30 kg/m2 (n, %) | 23 (14.9) | 7 (13.0) | 16 (16.0) | 0.79 |
Immunocompromised (n, %) | 19 (12.3) | 5 (9.3) | 14 (14.0) | 0.55 |
Pre-ECMO blood gases | ||||
pH | 7.11 (6.97–7.24) | 7.20 (7.07–7.31) | 7.06 (6.92–7.18) | <0.001 |
PaO2/FiO2 (mmHg) | 144.9 (60.0–209.0) | 146.7 (62.0–190.0) | 144.0 (52.5–212.5) | 0.21 |
PaCO2 (mmHg) | 47.3 (32.0–59.0) | 40.1 (31.0–51.0) | 51.3 (32.5–67.5) | 0.007 |
HCO3 - (mmol/L) | 13.7 (10.2–17.7) | 15.6 (13.2–18.4) | 12.7 (9.1–16.6) | 0.001 |
Mechanical ventilation | ||||
Plateau pressure (cmH2O) | 29.5 (27.0–32.0) | 28.5 (26.0–30.0) | 30.0 (27.0–33.0) | 0.06 |
Laboratory parameters | ||||
Lactate (mg/dL) | 97.4 (56.0–125.1) | 64.9 (40.0–75.0) | 115.2 (75.3–144.4) | <0.001 |
Hct (%) | 39.4 (35.0–45.0) | 39.6 (35.7–44.2) | 39.3 (34.3–45.4) | 0.93 |
Platelet count (× 103/μL) | 196.1 (147.0–242.0) | 216.8 (153.0–280.0) | 184.9 (124.5–224.0) | 0.036 |
Creatinine (mg/dL) | 1.97 (1.09–1.95) | 1.75 (0.98–1.90) | 2.09 (1.14–2.06) | 0.06 |
Bilirubin (mg/dL) | 1.02 (0.50–0.91) | 0.80 (0.50–0.81) | 1.13 (0.50–0.93) | 0.09 |
CRP | 3.25 (0.31–2.15) | 2.52 (0.22–1.21) | 3.65 (0.33–3.28) | 0.06 |
Vasopressors before ECMO (n, %) | 134 (87.0) | 26 (48.1) | 81 (81.0) | 0.21 |
Cardiac arrest before ECMO | ||||
IHCA (n, %) | 62 (40.3) | 18 (33.3) | 44 (44.0) | 0.09 |
OHCA (n, %) | 53 (34.4) | 12 (22.2) | 41 (41.0) | 0.031 |
SOFA score | 9.8 (7.0–13.0) | 8.7 (6.0–12.0) | 10.5 (8.0–13.0) | 0.004 |
SAVE score | –6.5 (–10.0– –3.0) | –3.2 (–7.0–2.0) | –8.3 (–11.0– –5.0) | <0.001 |